Slowing Aging One Organ At A Time

Aging seems to happen to the whole body at once. Hair turns gray, skin wrinkles, muscles weaken and memory fades. Recent epigenetic studies reveal that not all organs age at the same rate. Some tissues can age faster or slower than others.

Traditionally, most efforts to combat aging have focused on interventions that slow aging throughout the body. This study highlights a different approach. It asks if organs age at the same rate. The study focuses on modification rates across different organs and the ways these might be altered. This suggests there may be ways to change organ age without affecting the rest of the body. Targeting specific organs may extend healthy life by reducing the burden of aging in a crucial system.

Turning The Right Genes Up Or Down

DNA is the same in almost all cells, and they offer a wide range of variations and models. The body does not build every model at once. Cells use helper proteins, called gene regulators, to choose which model to build and which pages of the instruction book to ignore.

Building on this understanding of gene regulation, a recent study systematically screened approximately 200 transcription factors. These are special proteins that act like switches, turning genes on or off. The study screened these proteins to identify those capable of rejuvenating aged cells. It used fibroblasts, which are common cells found in connective tissue, such as skin. Aging was simulated in the lab. By comparing gene expression in aged and young fibroblasts, the study identified specific transcription factors whose activity changed with age.

To precisely control gene activity, the study used CRISPR-based gene modulation. This technology can increase or decrease the activity of specific genes. For this research, each transcription factor was tested individually in aged fibroblasts. More than a dozen of these changes improved how the cells functioned, restoring youthful patterns of gene activity, boosting their ability to handle stress and increasing their growth rate. These improvements were observed while maintaining their original identity as fibroblasts.

Making Old Livers Act Younger

The liver showed the most improvement. The liver processes nutrients, metabolizes drugs and chemicals, and removes them. It also stores and releases energy, and produces hormones for metabolism and immunity. Aging in the liver leads to more fat accumulation, fibrosis and impaired metabolic function. These changes contribute to fatty liver disease and problems with sugar metabolism. Maintaining a younger, healthier liver can significantly affect healthspan and longevity.

This study focused on CCAAT/enhancer-binding protein beta (C/EBPβ), a transcription factor that plays a central role in regulating metabolic processes and detoxification in liver cells. Under normal conditions, it helps maintain proper breakdown and storage of fats. It also supports glucose metabolism and enables the liver to respond to metabolic stress. With aging, both the levels and activity of the protein decline. This contributes to fat buildup, increased fibrosis and impaired liver detoxification.

In this experiment, gene therapy was used to increase the protein’s activity in the livers of aged mice by directly targeting the molecular changes that drive liver aging. After several weeks, the effects of enhanced protein activity were evaluated by measuring liver fat, fibrosis, blood sugar regulation and liver cell function. Boosting the protein led to healthier livers in aged mice. Fat accumulation and scarring were reduced. Blood sugar control also improved. Liver cells regained features typical of younger tissue. Importantly, there was no evidence of treatment-related liver damage or tumor formation.

These results demonstrate that specifically restoring C/EBPβ function can reverse key molecular and functional markers of liver aging in this animal model. If the liver remains functionally “younger” for longer, it could delay or reduce the onset of a wide range of age-related diseases, depending on liver health. This opens new avenues for research into reducing the effects of aging in the liver.

What This Means For Longevity Science

This work supports the idea that aging is not just wear and tear. Biological programs guide aging, and it may be possible to adjust them. It also shows that it’s not necessary to reverse aging to fully achieve meaningful benefits. Improvements in how cells and organs function could delay or reduce the onset of many age-related diseases.

These findings also provide a guide for future treatments. This approach can be used to find on-off switches in different tissues. Adjusting these switches could help the body function well for longer. Some switches might be changed with new types of medicine or by using techniques that increase or decrease the activity of certain gene regulators.

As I describe in my book Live Longer: What You Can Do, What Medicine Can Do, real progress in longevity comes from combining advances like this in the biology of aging with practical steps each of us can take in our daily lives. Together, these discoveries and day‑to‑day choices point toward a future in which living longer also means living better.

Read Dr. Haseltine's latest piece with

Forbes

© William A. Haseltine, PhD. All Rights Reserved.